Financial Year |
March 31 2023 |
Monetary Funds |
483,732,064.09 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
8,990,540.26 |
Accounts Receivable |
205,597,563.15 |
Advances to Suppliers |
1,628,166.54 |
Other Receivables |
21,514,942.74 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
104,741,081.30 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,357,542.14 |
Total Current Assets |
843,670,867.40 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
53,755,147.57 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,606,147.27 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
7,651,148.60 |
Deferred Income Tax Assets |
40,008,529.83 |
Other Non-Current Assets |
21,448,929.95 |
Sub-Total of Non-Current Assets |
167,720,548.46 |
Total Assets |
1,011,391,415.86 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
11,490,133.63 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
31,646,992.75 |
Taxes Payable |
15,823,231.04 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,136,529.72 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,839,057.18 |
Other Current Liabilities |
389,279.69 |
Sub-Total of Current Liabilities |
146,594,894.59 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
6,337,596.79 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
34,829,247.13 |
Total Liabilities |
181,424,141.72 |
Paid-In Capital(Or Share Stock) |
77,350,000.00 |
Capital Surplus |
625,333,001.39 |
Surplus Reserve |
17,682,688.59 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
90,890,598.54 |
Minority Stockholder's Interest |
18,708,448.35 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
811,258,825.79 |
Owner's Equity(Stockholder's Equity) |
829,967,274.14 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,011,391,415.86 |